Article Details
Retrieved on: 2019-05-14 06:29:51
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>A-R-T- Advisors Llc increased its stake in Esperion Therapeutics <b>Inc</b> Ne (ESPR) by 457.81% based on its latest 2018Q4 regulatory filing with the SEC.</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here